Natco Pharma Board Approves ₹1,069 Crore Adcock Ingram Stake Hike To 49%

Board approved investment of up to Rs 1,400 Cr in wholly-owned subsidiary Natco Pharma South Africa. Board also approved acquisition of additional stake in Adcock Ingram Holdings, increasing holding from 35.75% to 49% for ZAR 1.8 Bn (~Rs 1,069 Cr) in cash.